Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

M. Mian, N. Pescosta, S. Badiali, P.C. Cappelletto, L. Marcheselli, S. Luminari, F. Patriarca, R. Zambello, A. Pascarella, G. Tagariello, A. Marabese, P. Mondello, A. Billio, S. Cortelazzo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)944-947
Number of pages4
JournalBritish Journal of Haematology
Issue number5
Publication statusPublished - 2019

Cite this